<b>Gapping down<br/>In reaction to disappointing earnings/guidance:</b> TIF -3.9%, (reports holiday comps; guidance WIT -0.5%<br/><br/><b>M&A news:</b> SU -1.9% (Suncor Energy and Canadian Oil Sands (COSWF) amend acquisition offer), SAND -0.9% (Sandstorm Gold (SAND) has agreed to acquire 56 royalties from co for $22 mln)<br/><br/><b>Other news:</b> EBIO -52.3% (Phase 3 data on Isunakinra which missed primary endpoint of ocular itching), EC -4.9% (Moody's downgraded Ecopetrol to Baa3-triggered by persisting stressed oil prices; placed ratings on review for further downgrade), HDP -3.2% (files $100 mln common stock offering; also raises Q4 guidance (in line with estimates)), FTK -3% (announces retention of MHA Petroleum Consultants by CnF Special Technical Committee; Announces select, preliminary Q4 results; appointment of Independent Board Committee and SEC inquiry), SYT -2% (cont pre-mkt vol surrounding M&A spec), PBR -1.5% (reports its oil and natural gas production for 2015; period average of 2.128 mln barrels per day was 4.6% higher than the previous year ), HMY -1.2% (still checking), BLCM -0.5% (files $150 mln mixed securities shelf offering)<br/><b><br/>Analyst comments: </b>SRPT -2.7% (downgraded to Sector Perform at RBC Capital Mkt)<br/><br/><b>Gapping up <br/>In reaction to strong earnings/guidance:</b> UN +4.5%, MS +3%, DAL +2.2%, BAC +2%, SN +1.1%, CMA +1.1%, UNH +0.8%, FHN +0.8%, MTB +0.5%<br/><br/><b>M&A news:</b> BITI +80.8% (to be acquired by Acorda (ACOR) for $25.60 per ADS), RSE +26% (Brookfield Asset Management (BAM) proposes to acquire Rouse for $17.00/share in cash), SUNE +5.8% (acquires 33% stake in remaining 231 megawatt portion of Dominion's (D) 567 megawatt solar portfolio for $117 mln and sells said stake to Terra Nova for same price), ERIC +4.4% (Ericsson to acquire FYI TV), SHPG +3.1% (Barron's profiles positive view on Shire (SHPG) based on Baxalta (BXLT) M&A deal), TCK +1.6% (Teck Resources: Sandstorm Gold (SAND) has agreed to acquire 56 royalties from co for $22 mln), MSFT +1.4% (will be acquiring MinecraftEdu)<br/><b><br/>Select China related names showing strength: </b>JKS +9.5%, MOMO +5.5%, CSIQ +5.2%, JMEI +4.8%, SPWR +4.7%, QUNR +3.4%, JASO +3.4%, JD +3.3%, BABA +2.5%<br/><br/><b>Select metals/mining stocks trading higher:</b> MT +9.7%, CLF +7.1%, AU +4.9%, FCX +4.8%, BBL +3.1%, BHP +3%, AA +1.7%, VALE +0.8%<br/><br/><b>Other news: </b>CRDC +40% (Receives FDA clearance for expanded indications of Surgical Stapling Device), CANF +18.1% (announced that the USPTO has issued a Notice of Allowance for a patent titled, "A3 Adenosine Receptor Allosteric Modulators"), BSI +10.8% (Court grants temporary stay of legal proceedings against Mega Retail; also confirms it has received an number of offers to purchase the Company's holdings in Blue Square Real Estate), ZPIN +8.8% (received going private proposal valued at $17.50 per ADS and $8.75 per ordinary share), ATV +7% (cont strength), SNY +5.6% (strong EU mkts overnight), PUK +5.1% (still checking), TTM +5.1% (appoints new CEO), NRZ +5% (announces $200 mln share repurchase program), WMB +4.4% (Board is unanimously committed to completing the transaction with Energy Transfer Equity (ETE)), DDD +4.1% (still checking), INCY +2.9% (Incyte and Lilly (LLY) announce Submission of New Drug Application to FDA for Oral Once-Daily Baricitinib), BBRY +2.5% (reports co was awarded a $20 million multiple-year delivery order), CARA +2.1% (may be related to BITI merger), RIO +2.4% (reports Q4 production results), YHOO +2.1% (in symp with BABA), NVS +2% (received two new FDA approvals for Cosentyx to treat patients with ankylosing spondylitis and psoriatic arthritis in the US), GPRO +1.9% (strength in broader mkt this am), NFLX +1.9% (positive WSJD story), FB +1.8% (WhatsApp to pull its yearly subscription fee, test other monetization), BIIB +1.7% (reports EU approval for BENEPALI ), NGG +1.1% (Canadian funds are considering taking stake in NGG, according to Telegraph), SN +1.1% (reports average production of average production of 58,115 boe/day during the 4Q15; lowers 2016 Capital Budget guidance)<br/><br/><b>Analyst comments</b>: EXEL +5.9% (upgraded to Outperform from Mkt Perform at Leerink Partners), SHOP +5.8% (upgraded to Overweight from Equal-Weight at Morgan Stanley ), SHAK +4.8% (upgraded to Outperform from Market Perform at William Blair), P +4.8% (upgraded to Neutral at BTIG Research), KITE +4.4% (upgraded to Outperform from Mkt Perform at FBR Capital; tgt $75), SWIR +4.4% (upgraded to Outperform from Market Perform at Northland Capital), SWKS +3% (upgraded to Buy at Needham), AZN +1.9% (upgraded to Equal Weight, ResMed (RMD) downgraded to Underweight at Barclays) <br/><br/>Allikas: Briefing.com